SFM
Sphera Funds Management Portfolio holdings
AUM
$382M
This Quarter Return
+6.7%
1 Year Return
+0.41%
3 Year Return
+99.29%
5 Year Return
+177.09%
10 Year Return
+575.73%
AUM
$467M
AUM Growth
+$467M
(+1%)
Cap. Flow
-$18.4M
Cap. Flow
% of AUM
-3.94%
Top 10 Holdings %
Top 10 Hldgs %
35.86%
Holding
100
New
18
Increased
16
Reduced
23
Closed
17
Top Buys
| 1 |
Praxis Precision Medicines
PRAX
|
$10.1M |
| 2 |
Nova
NVMI
|
$8.21M |
| 3 |
SHLT
SHL Telemedicine Ltd American Depositary Shares
SHLT
|
$7.96M |
| 4 |
Alnylam Pharmaceuticals
ALNY
|
$7.6M |
| 5 |
Day One Biopharmaceuticals
DAWN
|
$6.33M |
Top Sells
| 1 |
Nutrien
NTR
|
$10.7M |
| 2 |
Invesco QQQ Trust
QQQ
|
$8.46M |
| 3 |
Eli Lilly
LLY
|
$7.5M |
| 4 |
Teva Pharmaceuticals
TEVA
|
$7.45M |
| 5 |
Microsoft
MSFT
|
$6.92M |
Sector Composition
| 1 | Healthcare | 78.63% |
| 2 | Technology | 13.25% |
| 3 | Consumer Discretionary | 3.47% |
| 4 | Utilities | 0.8% |
| 5 | Industrials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Camtek
CAMT
$3.51B
| $6.75M | 1.05% |
189,494
-50,000
| -21% | -$1.78M |
|
27
Kura Oncology
KURA
$732M
| $6.38M | 1% |
603,287
| – | – |
|
|
28
Day One Biopharmaceuticals
DAWN
$766M
| $6.33M | 0.99% |
+530,000
| New | +$6.33M |
|
|
INZY
29
DELISTED
Inozyme Pharma
INZY
| $6.31M | 0.98% |
1,131,967
-649,891
| -36% | -$3.62M |
|
30
Tower Semiconductor
TSEM
$6.96B
| $6.28M | 0.98% |
+167,446
| New | +$6.28M |
|
|
FUSN
31
DELISTED
Fusion Pharmaceuticals Inc. Common Shares
FUSN
| $6.21M | 0.97% |
1,329,258
+45,721
| +4% | +$214K |
|
32
Novartis
NVS
$248B
| $6.05M | 0.95% |
60,000
| – | – |
|
|
SAGE
33
DELISTED
Sage Therapeutics
SAGE
| $6.02M | 0.94% |
128,000
-27,000
| -17% | -$1.27M |
|
34
Jasper Therapeutics
JSPR
$44.2M
| $5.86M | 0.91% |
4,274,008
+230,000
| +6% | +$315K |
|
35
Madrigal Pharmaceuticals
MDGL
$9.7B
| $5.78M | 0.9% |
25,000
+6,000
| +32% | +$1.39M |
|
36
Sarepta Therapeutics
SRPT
$1.98B
| $5.73M | 0.89% |
50,000
+6,000
| +14% | +$687K |
|
37
BridgeBio Pharma
BBIO
$9.91B
| $5.53M | 0.86% |
321,635
-240,348
| -43% | -$4.13M |
|
38
Celldex Therapeutics
CLDX
$1.57B
| $5.43M | 0.85% |
+160,000
| New | +$5.43M |
|
|
ISEE
39
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $5.29M | 0.83% |
134,414
-97,177
| -42% | -$3.82M |
|
|
MORF
40
DELISTED
Morphic Holding, Inc. Common Stock
MORF
| $5.16M | 0.81% |
+90,000
| New | +$5.16M |
|
41
Pfizer
PFE
$141B
| $5.14M | 0.8% |
140,000
| – | – |
|
42
Cogent Biosciences
COGT
$1.83B
| $4.97M | 0.78% |
420,000
+120,000
| +40% | +$1.42M |
|
43
Kezar Life Sciences
KZR
$28.5M
| $4.87M | 0.76% |
1,988,228
+100,000
| +5% | +$245K |
|
44
Rocket Pharmaceuticals
RCKT
$358M
| $4.69M | 0.73% |
236,000
| – | – |
|
|
GRCL
45
DELISTED
Gracell Biotechnologies Inc. American Depositary Shares
GRCL
| $4.68M | 0.73% |
1,228,665
-1,131,915
| -48% | -$4.31M |
|
46
SPDR S&P Biotech ETF
XBI
$5.29B
| $4.16M | 0.65% |
+50,000
| New | +$4.16M |
|
47
PTC Therapeutics
PTCT
$4.41B
| $4.07M | 0.64% |
100,100
-59,000
| -37% | -$2.4M |
|
48
Astria Therapeutics
ATXS
$394M
| $3.92M | 0.61% |
471,018
+50,000
| +12% | +$417K |
|
49
Qualcomm
QCOM
$170B
| $3.81M | 0.59% |
+32,000
| New | +$3.81M |
|
50
Enlight Renewable Energy
ENLT
$3.35B
| $3.76M | 0.59% |
211,586
-239,278
| -53% | -$4.25M |
|